Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2

Vaccine

Volumn 29, Issue 17, 2011, Pages 3206-3212

  Kim, D ^a   Kim, C H ^a   Han, K ^a   Seo, H W ^a   Oh, Y ^a   Park, C ^a   Kang, I ^a   Chae, C ^a  

^a Seoul National University   (South Korea)

Author keywords

Mycoplasma hyopneumoniae; Porcine circovirus 2; Porcine circovirus associated disease; Porcine respiratory disease complex; Vaccine efficacy

Indexed keywords

BACTERIAL DNA; BACTERIAL VACCINE; BACTERIN; BACTERIUM ANTIBODY; CIRCOFLEX; IMMUNOGLOBULIN G ANTIBODY; MYCOFLEX; MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE; PORCINE CIRCOVIRUS 2 VACCINE; RESPISURE ONE; SUVAXYN PCV2; UNCLASSIFIED DRUG; VETERINARY DRUG; VIRUS ANTIBODY; VIRUS DNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENOME; BACTERIUM DETECTION; CIRCOVIRUS; CIRCOVIRUS TYPE 2; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; GENE DOSAGE; GROUPS BY AGE; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LUNG LESION; MIXED INFECTION; MYCOPLASMA HYOPNEUMONIAE; MYCOPLASMOSIS; NONHUMAN; NOSE SMEAR; PIGLET; PRIORITY JOURNAL; PROVOCATION TEST; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SEROLOGY; SINGLE DRUG DOSE; SWINE DISEASE; VACCINATION; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; WEIGHT GAIN;

ANIMALS; BACTERIAL VACCINES; BODY WEIGHT; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; LUNG; LYMPH NODES; MYCOPLASMA HYOPNEUMONIAE; NASAL CAVITY; PNEUMONIA OF SWINE, MYCOPLASMAL; SERUM; SWINE; TREATMENT OUTCOME; VIRAL VACCINES;

EID: 79954604719     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.034     Document Type: Article

References (39)

1. Chae C. Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology. Vet J 2004, 168(1 (July)):41-49.
2. Chae C. A review of porcine circovirus 2-associated syndromes and diseases. Vet J 2005, 169(3 (May)):326-336.
3. Kim J., Chung H.K., Chae C. Association of porcine circovirus 2 with porcine respiratory disease complex. Vet J 2003, 166(3 (November)):251-256.
4. Kim J., Chung H.K., Jung T., Cho W.S., Choi C., Chae C. Postweaning multisystemic wasting syndrome of pigs in Korea: prevalence, microscopic lesions and coexisting microorganisms. J Vet Med Sci 2002, 64(1 (January)):57-62.
5. Baccaro M.R., Hirose F., Umehara O., Goncalves L.C., Doto D.S., Paixao R., et al. Comparative efficacy of two single-dose bacterins in the control of Mycoplasma hyopneumoniae in swine raised under commercial conditions in Brazil. Vet J 2006, 172(3 (November)):526-531.
6. Cline G., Wilt V., Diaz E., Edler R. Efficacy of immunising pigs against porcine circovirus type 2 at three or six weeks of age. Vet Rec 2008, 163(25 (December)):737-740.
7. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., et al. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J Am Vet Med Assoc 2008, 232(6 (March)):906-912.
8. Reynolds S.C., St.Aubin L.B., Sabbadini L.G., Kula J., Vogelaar J., Runnels P., et al. Reduced lung lesions in pigs challenged 25 weeks after the administration of a single dose of Mycoplasma hyopneumoniae vaccine at approximately 1 week of age. Vet J 2009, 181(3 (September)):312-320.
9. Bergstrom J.R., Potter M.L., Tokach M.D., Henry S.C., Dritz S.S., Nelssen J.L., et al. Effects of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccination strategy, birth weight, and gender on postweaning performance of growing-finishing pigs reared in a commercial environment. Proceedings of the Kansas Swine Day Conference 2009, 8-20.
10. Kim J., Choi C., Chae C. Pathogenesis of postweaning multisystemic wasting syndrome reproduced by co-infection with Korean isolates of porcine circovirus 2 and porcine parvovirus. J Comp Pathol 2003, 128(1 (January)):52-59.
11. Krakowka S., Ellis J.A., Meehan B., Kennedy S., McNeilly F., Allan G. Viral wasting syndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and porcine parvovirus. Vet Pathol 2000, 37(3 (May)):254-263.
12. Kwon D., Choi C., Chae C. Chronologic localization of Mycoplasma hyopneumoniae in experimentally infected pigs. Vet Pathol 2002, 39(5 (September)):584-587.
13. Patterson A.R., Johnson J., Ramamoorthy S., Meng X.J., Halbur P.G., Opriessnig T. Comparison of three enzyme-linked immunosorbent assays to detect porcine circovirus-2 (PCV-2)-specific antibodies after vaccination or inoculation of pigs with distinct PCV-1 or PCV-2 isolates. J Vet Diagn Invest 2008, 20(6 (November)):744-751.
14. Dubosson C.R., Conzelmann C., Miserez R., Boerlin P., Frey J., Zimmermann W., et al. Development of two real-time PCR assays for the detection of Mycoplasma hyopneumoniae in clinical samples. Vet Microbiol 2004, 102(1-2 (August)):55-65.
15. Fierer N., Jackson J.A., Vilgalys R., Jackson R.B. Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl Environ Microbiol 2005, 71(7 (July)):4117-4120.
16. Gagnon C.A., del Castillo J.R., Music N., Fontaine G., Harel J., Tremblay D. Development and use of a multiplex real-time quantitative polymerase chain reaction assay for detection and differentiation of porcine circovirus-2 genotypes 2a and 2b in an epidemiological survey. J Vet Diagn Invest 2008, 20(5 (September)):545-558.
17. Halbur P.G., Paul P.S., Frey M.L., Landgraf J., Eernisse K., Meng X.J., et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995, 32(6 (November)):648-660.
18. Straw B.E., Backstrom L., Leman A.D. Examination of swine at slaughter. Part II. Findings at slaughter and their significance. Comp Contin Educ Pract Vet 1986, 8(2 (February)):S106-S122.
19. Jung K., Ha Y., Chae C. Pathogenesis of swine influenza virus subtype H1N2 infection in pigs. J Comp Pathol 2005, 132(2-3 (February-April)):179-184.
20. Kim J., Chae C. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 in porcine circovirus 2-induced granulomatous inflammation. J Comp Pathol 2004, 131(2-3 (August-October)):121-126.
21. West K.H., Bystrom J.M., Wojnarowicz C., Shantz N., Jacobson M., Allan G.M., et al. Myocarditis and abortion associated with intrauterine infection of sows with porcine circovirus 2. J Vet Diagn Invest 1999, 11(6 (November)):530-532.
22. Kim J., Chae C. A comparison of virus isolation, polymerase chain reaction, immunohistochemistry, and in situ hybridization for the detection of porcine circovirus 2 and porcine parvovirus in experimentally and naturally coinfected pigs. J Vet Diagn Invest 2004, 16(1 (January)):45-50.
23. Waag T.A., Bradford J.R., Lucas M.J., Rooney K.A., Nutsch R.G., Lechtenberg K.F., et al. Duration of effectiveness of tulathromycin injectable solution in an Actinobacillus pleuropneumoniae respiratory disease challenge model in swine. J Swine Health Prod 2008, 16(3 (May)):126-130.
24. Sibila M., Nofrarias M., Lopez-Soria S., Segales J., Valero O., Espinal A., et al. Chronological study of Mycoplasma hyopneumoniae infection, seroconversion and associated lung lesions in vaccinated and non-vaccinated pigs. Vet Microbiol 2007, 122(1-2 (May)):97-107.
25. Thacker E.L. Mycoplasmal disease. Diseases of swine 2006, 701-717. Iowa State University Press, Ames. B. Straw, J. Zimmermann, S. D'Allaire, D. Taylor (Eds.).
26. Fano E., Pijoan C., Dee S., Deen J. Effect of Mycoplasma hyopneumoniae colonization at weaning on disease severity in growing pigs. Can J Vet Res 2007, 71(3 (July)):195-200.
27. Martelli P., Terreni M., Guazzetti S., Cavirani S. Antibody response to Mycoplasma hyopneumoniae infection in vaccinated pigs with or without maternal antibodies induced by sow vaccination. J Vet Med B Infect Dis Vet Public Health 2006, 53(5 (June)):229-233.
28. Opriessnig T., Patterson A.R., Elsener J., Meng X.J., Halbur P.G. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2. Clin Vaccine Immunol 2008, 15(3 (March)):397-401.
29. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Ramamoorthy S., Meng X.J., et al. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination. Vet Microbiol 2010, 142(3-4 (May)):177-183.
30. Krakowka S., Ellis J., McNeilly F., Waldner C., Rings D.M., Allan G. Mycoplasma hyopneumoniae bacterins and porcine circovirus type 2 (PCV2) infection: induction of postweaning multisystemic wasting syndrome (PMWS) in the gnotobiotic swine model of PCV2-associated disease. Can Vet J 2007, 48(7 (July)):716-724.
31. Opriessnig T., Thacker E.L., Yu S., Fenaux M., Meng X.J., Halbur P.G. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet Pathol 2004, 41(6 (November)):624-640.
32. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27(7 (February)):1002-1007.
33. Larochelle R., Magar R., D'Allaire S. Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome. Can J Vet Res 2003, 67(2 (May)):114-120.
34. Meerts P., Misinzo G., Lefebvre D., Nielsen J., Botner A., Kristensen C.S., et al. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet Res 2006, 2:6.
35. Meerts P., Van Gucht S., Cox E., Vandebosch A., Nauwynck H.J. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol 2005, 18(2):333-341.
36. Fort M., Olvera A., Sibila M., Segales J., Mateu E. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Vet Microbiol 2007, 125(3-4 (December)):244-255.
37. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segales J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26(8 (February)):1063-1071.
38. Kixmoller M., Ritzmann M., Eddicks M., Saalmuller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26(27-28 (June)):3443-3451.
39. Opriessnig T., Madson D.M., Prickett J.R., Kuhar D., Lunney J.K., Elsener J., et al. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection. Vet Microbiol 2008, 131(1-2 (September)):103-114.